ARCHIVES

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

ACS Offers New Grants to Physicians

September 7, 1984

FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.

March 31, 2000

BSA Working Group

November 12, 2010

Also NY State Initiatives Would Fund Research Using I-ELCAP Protocol for CT Scanning for Lung Cancer.

May 4, 2007

In Brief: “Massive Reassessment” Of Centers Going On, Tim Talbot Believes; WHO Drops ICRB Service

December 9, 1977

NCI, Dialogue Plan A National Tissue Bank

July 11, 2003